Therapeutic indications
Amoxicillin is indicated for:
Acute bacterial sinusitis
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Acute bacterial sinusitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 250-1000mg 3 times a day
Treatment 2:
Oral
- 750-1000mg 2 times a day
Treatment 3:
Intravenous
- 0.75-2gr 3 times a day
Treatment 4:
Intravenous
- 2gr 2 times a day
Treatment 5:
Intramuscular
- 0.75-1gr 3 times a day
Acute pyelonephritis
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Acute pyelonephritis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 250-1000mg 3 times a day
Treatment 2:
Oral
- 750-1000mg 2 times a day
Treatment 3:
Intravenous
- 0.75-2gr 3 times a day
Treatment 4:
Intravenous
- 2gr 2 times a day
Treatment 5:
Intramuscular
- 0.75-1gr 3 times a day
Dental abscess with spreading cellulitis
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Dental abscess and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 250-1000mg 3 times a day
Treatment 2:
Oral
- 750-1000mg 2 times a day
Treatment 3:
Intravenous
- 0.75-2gr 3 times a day
Treatment 4:
Intravenous
- 2gr 2 times a day
Treatment 5:
Intramuscular
- 0.75-1gr 3 times a day
Asymptomatic bacteriuria in pregnancy
Population group: women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Asymptomatic bacteriuria in pregnancy and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 250-1000mg 3 times a day
Treatment 2:
Oral
- 750-1000mg 2 times a day
Acute cystitis
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Acute cystitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 250-1000mg 3 times a day
Treatment 2:
Oral
- 750-1000mg 2 times a day
Treatment 3:
Oral
- 3gr 2 times a day
Treatment 4:
Intravenous
- 0.75-2gr 3 times a day
Treatment 5:
Intravenous
- 2gr 2 times a day
Treatment 6:
Intramuscular
- 0.75-1gr 3 times a day
Acute otitis media
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Acute otitis media and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 0,5-1gr 3 times a day
Treatment 2:
Oral
- 0,75-1gr 2 times a day
Acute streptococcal tonsillitis and pharyngitis
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
at least one of
Streptococcal tonsillitis
Streptococcal sore throat
and additionally at least one of
Streptococcus agalactiae
Streptococcus pyogenes
Streptococcus agalactiae
Streptococcus, group C
Streptococcus, group G
Streptococcus, viridans group
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 0,5-1gr 3 times a day
Treatment 2:
Oral
- 0,75-1gr 2 times a day
Acute exacerbations of chronic bronchitis
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Acute exacerbation of chronic bronchitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 0,5-1gr 3 times a day
Treatment 2:
Oral
- 0,75-1gr 2 times a day
Treatment 3:
Intravenous
- 0.75-2gr 3 times a day
Treatment 4:
Intravenous
- 2gr 2 times a day
Treatment 5:
Intramuscular
- 0.75-1gr 3 times a day
Community acquired pneumonia
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Community acquired pneumonia and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 0,5-1gr 3 times a day
Treatment 2:
Intravenous
- 0.75-2gr 3 times a day
Treatment 3:
Intravenous
- 2gr 2 times a day
Treatment 4:
Intramuscular
- 0.75-1gr 3 times a day
Typhoid and paratyphoid fever
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
† Typhoid and paratyphoid fevers and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 0.5-2gr 3 times a day
Prosthetic joint infection
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Infected arthroplasty and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 0,5-1 gr 3 times a day
Treatment 2:
Intramuscular
- 0.75-1 gr 3 times a day
Treatment 3:
Intravenous
- 0.75-1 gr 3 times a day
Prophylaxis of endocarditis
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Preventive procedure and additionally
Endocarditis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 2gr once
Treatment 2:
Intravenous
- 2gr once
Helicobacter pylori eradication
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Helicobacter pylori gastrointestinal tract infection
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 0.75-1gr twice daily
Lyme disease
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 0.5-2gr 3 times a day
Treatment 2:
Intravenous
- 2gr 3 times a day
Acute bacterial sinusitis
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
Acute bacterial sinusitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 20-90 mg/kg/day in 3 divided doses
Treatment 2:
Intravenous
- 20-200 mg/kg/day in 4 equal divided doses
Acute otitis media
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
Acute otitis media and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 20-90 mg/kg/day in 3 divided doses
Treatment 2:
Intravenous
- 20-200 mg/kg/day in 4 equal divided doses
Community acquired pneumonia
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
Community acquired pneumonia and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 20-90 mg/kg/day in 3 divided doses
Acute cystitis
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
Acute cystitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 20-90 mg/kg/day in 3 divided doses
Acute pyelonephritis
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
Acute pyelonephritis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 20-90 mg/kg/day in 3 divided doses
Treatment 2:
Intravenous
- 20-200 mg/kg/day in 4 equal divided doses
Dental abscess with spreading cellulitis
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
Dental abscess and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 20-90 mg/kg/day in 3 divided doses
Treatment 2:
Intravenous
- 20-200 mg/kg/day in 4 equal divided doses
Acute streptococcal tonsillitis and pharyngitis
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
at least one of
Streptococcal tonsillitis
Streptococcal sore throat
and additionally at least one of
Streptococcus agalactiae
Streptococcus pyogenes
Streptococcus agalactiae
Streptococcus, group C
Streptococcus, group G
Streptococcus, viridans group
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 40-90 mg/kg/day in 3 divided doses
Treatment 2:
Intravenous
- 20-200 mg / kg / day in 4 equal divided doses
Typhoid and paratyphoid fever
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
† Typhoid and paratyphoid fevers
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 100 mg/kg/day in three divided doses
Prophylaxis of endocarditis
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
Preventive procedure and additionally
Endocarditis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 50 mg/kg once
Treatment 2:
Intravenous
- Single dose 50 mg/kg 30-60 minutes before the procedure
Lyme disease
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Oral
- 25-100 mg/kg/day in three divided doses
Treatment 2:
Intravenous
- 25-150 mg / kg / day in 4 divided doses
Endocarditis
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Endocarditis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Intravenous
- 1-2 gr 6 times a day
Bacterial meningitis
Population group: both men and women,
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
Bacterial meningitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Intravenous
- 1-2gr 6 times a day
Endocarditis
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
Endocarditis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Intravenous
- 100-200 mg/kg/day in 4 equal divided doses
Bacterial meningitis
Population group: both men and women,
only
newborns (0 - 40 days old)
, infants (40 days - 1 year old)
, children (1 year - 12 years old)
Bacterial meningitis and additionally at least one of
Amoxicillin susceptible species
Amoxicillin susceptible species for which acquired resistance may be a problem
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Treatment 1:
Intravenous
- 100-200 mg/kg/day in 4 equal divided doses